Alyeska Investment Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-536,847
| Closed | -$2.08M | – | 946 |
|
|
2020
Q4 | $2.08M | Buy |
536,847
+45,706
| +9% | +$177K | 0.03% | 363 |
|
|
2020
Q3 | $1.98M | Buy |
491,141
+139,716
| +40% | +$563K | 0.03% | 354 |
|
|
2020
Q2 | $1.5M | Buy |
+351,425
| New | +$1.5M | 0.02% | 360 |
|
|
2020
Q1 | – | Sell |
-643,444
| Closed | -$2.53M | – | 524 |
|
|
2019
Q4 | $2.53M | Buy |
+643,444
| New | +$2.53M | 0.03% | 267 |
|
|
2019
Q2 | – | Sell |
-315,910
| Closed | -$2.03M | – | 535 |
|
|
2019
Q1 | $2.03M | Buy |
+315,910
| New | +$2.03M | 0.03% | 256 |
|
|
2018
Q4 | – | Sell |
-125,000
| Closed | -$2.52M | – | 522 |
|
|
2018
Q3 | $2.52M | Buy |
125,000
+75,000
| +150% | +$1.51M | 0.03% | 266 |
|
|
2018
Q2 | $1.46M | Buy |
50,000
+28,925
| +137% | +$844K | 0.01% | 348 |
|
|
2018
Q1 | $628K | Buy |
+21,075
| New | +$628K | 0.01% | 378 |
|
|
2017
Q3 | – | Sell |
-80,583
| Closed | -$2.4M | – | 577 |
|
|
2017
Q2 | $2.4M | Buy |
80,583
+5,583
| +7% | +$166K | 0.02% | 314 |
|
|
2017
Q1 | $2.24M | Buy |
+75,000
| New | +$2.24M | 0.02% | 379 |
|